Foresight Science & Technology (United States)

Recent papers from Foresight Science & Technology (United States)

1. Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin LymphomaJournal of Clinical Oncology · 2026
2. Eicosapentaenoic acid in emotional well-being and brain aging: evidence boundaries, clinical heterogeneity, and a peripheral-to-central resolution-biology frameworkFrontiers in Nutrition · 2026
3. Phase 2 trial of lisocabtagene maraleucel for minimal residual disease in patients with large B-cell lymphoma.Journal of Clinical Oncology · 2026
4. Assessment of Potential Sources of Variability on the Analytical Performance of a Circulating Tumor DNA Minimal Residual Disease Test for B‐Cell LymphomasJournal of Clinical Laboratory Analysis · 2026
5. Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard TherapyJournal of Clinical Oncology · 2026
6. Effect of Alloying on Microstructure and Transport Properties in the Catalyst Layer of Proton Exchange Membrane Fuel CellsACS Applied Energy Materials · 2026
7. Abstract 4519: FS-207: A potential best-in-class WRN helicase inhibitor for treating MSI-H cancers.Cancer Research · 2026
8. Dazdotuftide: Novel Treatment for Noninfectious Uveitis with Superior Intraocular Pressure Safety Profile: A Randomized Clinical TrialAmerican Journal of Ophthalmology · 2026
9. Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell LymphomaJournal of Clinical Oncology · 2025
10. The dual use of artificial intelligence: Analysis of trends and policies in the defence space sectorInternational Journal of Engineering Business Management · 2025
11. The dual use of artificial intelligence: Analysis of trends and policies in the defence space sectorInternational Journal of Engineering Business Management · 2025
12. Remission Assessment by Circulating Tumor DNA in Large B-cell LymphomaJournal of Clinical Oncology · 2025
13. Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trialNature Communications · 2025
14. Peer support: Current status and future opportunities for college mental health promotionJournal of American College Health · 2025
15. Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignanciesOncotarget · 2025
16. 3D Morphological and Volumetric Assessment of the Sella Turcica on CT Scans: A Comparative Study of Males and Females in Jos, North Central NigeriaEuropean Journal of Medical and Health Research · 2025
17. Fast, cost-effective AI solution for aspherical surface measurementOptical Engineering · 2025
18. Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevityAging · 2024
19. Analytical Validation of a Circulating Tumor DNA Assay using PhasED-Seq Technology for Detecting Residual Disease in B-Cell Malignancies2024
20. Identifying Children and Adolescents at Elevated Mental Health Risk Before and During COVID-19Journal of Developmental & Behavioral Pediatrics · 2024